Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$6.97−0.15 (-2.11%)
Close on Nov 17, 2026Market cap $418.93MP/E –Yield –
Orchestra BioMed price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Orchestra BioMed's price to sales ratio was 11.3× on Nov 11, 2026, against 106.6× a year earlier. Over the last 4 years it ranged from 6.8× to 131.6×, with a median of 58.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.3× | −71.9 |
| 2025 | Dec 31, 2025 | 83.2× | +25.8 |
| 2024 | Dec 31, 2024 | 57.3× | −33.3 |
| 2023 | Dec 29, 2023 | 90.6× | – |
See a number that looks wrong?